Biogerontology, "anti-aging medicine," and the challenges of human enhancement

Hastings Cent Rep. 2003 Jul-Aug;33(4):21-30.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging / drug effects*
  • Aging / physiology
  • Biomedical Enhancement / ethics*
  • Biotechnology / trends*
  • Cellular Senescence / drug effects
  • Cellular Senescence / physiology
  • Geriatrics / trends*
  • Humans
  • Longevity / drug effects*
  • Longevity / physiology
  • Philosophy, Medical
  • Quality of Life
  • United States
  • United States Food and Drug Administration